Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial
about
Pneumococcal vaccination during pregnancy for preventing infant infectionOntogeny of early life immunityA longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort studyStreptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era.The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Adjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.Maternal and neonatal pneumococcal vaccination - where are we now?Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccination.Effect of maternally-derived anti-protein and anti-capsular IgG antibodies on the rate of acquisition of nasopharyngeal carriage of pneumococcus in newborns.Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.Vaccine responses in newborns.Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.Neonatal Immunization: Rationale, Current State, and Future Prospects.Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of in Papua New Guinean children: A randomized controlled trial
P2860
Q24186525-E6627B28-F428-46A9-A75F-A78E461D0F80Q27000632-34FE0722-97F0-4B86-A157-E261BA19FC73Q33802029-C8D23C02-97A9-4164-A4FD-1D6F37CAE0C3Q35828587-3BDFA0C5-8970-44D5-AD01-DC2574FFC93FQ36713715-4830165E-6F97-4B63-ADFF-BC389FC40406Q37372321-91F2BD47-EB92-45FA-A077-0F4DBCB563F7Q38948154-9253C550-D356-48BF-B78C-B8E11D18ACDEQ39484402-88F0A3E9-772E-48C3-BCC8-C9C891B738E3Q41987151-1F601F80-ABC7-4802-85C8-B94CEAD60896Q42701700-1F1399BE-1F56-4934-9036-47BE3FD29B3BQ46301580-3D8D8CA9-FB2F-452F-99B7-C2CFA78F3AA0Q47098110-E54EBAB2-8A28-4AD2-B3AA-2D766964C021Q52579157-9CBCA23D-A635-4656-A14A-080CA9DA4E54Q57272219-CBF55570-B949-44A0-A82A-1A4B2FFFB327
P2860
Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety and immunogenicity of n ...... a randomised controlled trial
@ast
Safety and immunogenicity of n ...... a randomised controlled trial
@en
Safety and immunogenicity of n ...... a randomised controlled trial
@nl
type
label
Safety and immunogenicity of n ...... a randomised controlled trial
@ast
Safety and immunogenicity of n ...... a randomised controlled trial
@en
Safety and immunogenicity of n ...... a randomised controlled trial
@nl
prefLabel
Safety and immunogenicity of n ...... a randomised controlled trial
@ast
Safety and immunogenicity of n ...... a randomised controlled trial
@en
Safety and immunogenicity of n ...... a randomised controlled trial
@nl
P2093
P2860
P50
P1433
P1476
Safety and immunogenicity of n ...... a randomised controlled trial
@en
P2093
Anita H J van den Biggelaar
Deborah Lehmann
Jacinta Francis
Michael P Alpers
Neonatal Pneumococcal Conjugate Vaccine Trial Study Team
Peter C Richmond
Peter Jacoby
Suparat Phuanukoonnon
William S Pomat
P2860
P304
P356
10.1371/JOURNAL.PONE.0056698
P407
P577
2013-02-22T00:00:00Z